about/contact | site map | advertising


GE, Dyax announce licensing agreement
Article Thumbnail ImageApril 2, 2012 -- GE Healthcare and biopharmaceutical company Dyax announced a licensing agreement to develop and commercialize peptides binding to c-Met, a growth-factor receptor.

To view the remainder of this article, and other exclusive content, you must first sign-in or register using the options below.
(Helptag:PaywallArticleLoginMessage)
Member Sign In:
  MemberID or E-mail Address:
  Password:
(?)
Forgot your password? Click here.

View our privacy policy
New AuntMinnie.com Members

Becoming a Member is FREE!

  • Real-time radiology-specific news
  • Case of the Day and Teaching Files
  • Focused topics digital communities
  • Lively, discussion groups
  • Medical imaging bookstore
  • SalaryScan
  • Job Boards
  • OnLine CMe/CE
  • Bookstore, market reports, more …
  • Conference Calendar
  • User-controlled eNewsletters
  • … registration is FREE and easy!
    		•

    The license includes application of the peptides in PET, SPECT, and optical imaging. GE said it will research c-Met's potential diagnostic applications and use as a patient selection biomarker in oncology, in collaboration with academic institutions and pharmaceutical companies.

    || About || Advertising || Bookstore || Breast MRI || Career Center || Case of the Day || Communities || Conferences || Contact Us || ECR News 2013 || Education || Equipment Classifieds || Facebook || Forums || Home || Links || Marketplace || Mobile || Molecular Breast Imaging || New Installations || News in Brief || People in the News || Privacy Policy || RSNA News 2012 || Reference || Salary Survey Results || Trends in Radiology || Twitter || Vendor Connect || Webinars || XML/RSS ||

    Copyright © 2013 AuntMinnie.com. All Rights Reserved.